Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction

ARYA Atherosclerosis

Volumn 9, Issue 2, 2013, Pages 134-139

  Vakili, Hossein ^a   Sadeghi, Roxana ^a   Tabkhi, Mahdiye ^a   Safi, Morteza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Corrected thrombolysis in myocardial infarction frame count; Ejection fraction; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; ENALAPRIL; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; LOSARTAN;

ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; DEATH; DISEASE ASSOCIATION; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBECTOMY; VASCULAR DISEASE;

EID: 84876171909     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kushner FG, Hand M, Smith SC, Jr., King SB, III, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54(23): 2205-41.
2. Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: a case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol 2003; 26(7): 319-22.
3. Gibson CM, Cannon CP, Daley WL, Dodge JT, Jr., Alexander B, Jr., Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93(5): 879-88.
4. Faile BA, Guzzo JA, Tate DA, Nichols TC, Smith SC, Dehmer GJ. Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow. Am Heart J 2000; 140(2): 308-14.
5. Vijayalakshmi K, Kunadian B, Whittaker VJ, Williams D, Wright RA, Sutton AG, et al. The impact of chronically diseased coronary arteries and stenting on the corrected TIMI frame count in elective coronary angiography and percutaneous coronary intervention procedures. Catheter Cardiovasc Interv 2007; 70(5): 691-700.
6. French JK, Hyde TA, Straznicky IT, Andrews J, Lund M, Amos DJ, et al. Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. J Am Coll Cardiol 2000; 35(6): 1516-24.
7. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50(22): 2173-95.
8. Stoel MG, De Cock CC, Spruijt HJ, Zijlstra F, Visser CA. Corrected TIMI frame count and frame count velocity. Neth Heart J 2003; 11(3): 109-12.
9. Dodge JT, Jr., Rizzo M, Nykiel M, Altmann J, Hobkirk K, Brennan M, et al. Impact of injection rate on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count. Am J Cardiol 1998; 81(10): 1268-70.
10. Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001; 38(3): 666-71.
11. Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 1999; 99(15): 1945-50.
12. Gibson CM, Goel M, Cohen DJ, Piana RN, Deckelbaum LI, Harris KE, et al. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. J Am Coll Cardiol 1998; 32(1): 28-34.
13. Andrews J, Straznicky IT, French JK, Green CL, Maas AC, Lund M, et al. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation 2000; 101(18): 2138-43.
14. Bhatt DL, Ellis SG, Ivanc TB, Crowe T, Balazs E, Debowey D, et al. Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction. Am Heart J 1999; 138(4 Pt 1): 785-90.
15. Nielsen PH, Maeng M, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, et al. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Circulation 2010; 121(13): 1484-91.